Literature DB >> 9216010

Silicone oil for recurrent vitreous hemorrhage in previously vitrectomized diabetic eyes.

S Bodanowitz1, N Kir, L Hesse.   

Abstract

AIMS: To investigate the clinical course of vitrectomized patients with recurrent diabetic vitreous hemorrhage who were treated by revitrectomy with silicone oil (SO) as a hemostyptic tamponade. PATIENTS AND METHODS: Fifteen patients with recurrent vitreous hemorrhage due to proliferative diabetic vitreoretinopathy were included in this retrospective study. All eyes had had at least one vitrectomy prior to use of SO and the retina was completely attached at any time before revitrectomy with SO instillation. Thirteen patients had a blind fellow eye. There were 6 males and 9 females (mean age 62.7 years, range 45-76 years). The mean duration of SO tamponade was 25.8 months (range 9-35 months). The average follow-up period was 30.4 months (range 20-48 months).
RESULTS: Ten out of 15 eyes (66.6%) improved postoperatively, 9 eyes had a visual acuity of > or = 0.02 at the latest follow-up visit. Secondary glaucoma occurred in 4 eyes, leading to phthisis in 1 eye. All 5 phakic eyes developed a cataract.
CONCLUSION: A revitrectomy combined with a long-term hemostyptic SO tamponade offers a chance for restoration of useful visual acuity in diabetic eyes with persistent vitreous-hemorrhage that fails to subside after cryocoagulation and vitrectomy without tamponade. Because of possible visual loss from secondary glaucoma related to intraocular SO this treatment should mainly be considered in patients with a blind fellow eye.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9216010     DOI: 10.1159/000310793

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  5 in total

1.  Measurement of axial length of eyes with incomplete filling of silicone oil in the vitreous cavity using x ray computed tomography.

Authors:  Kazuo Takei; Yasuo Sekine; Fumiki Okamoto; Sachiko Hommura
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

2.  Outcome and significance of silicone oil tamponade in patients with chronic serous retinal detachment.

Authors:  Pan Sang Kim; Chang Wook Choi; Yun Sik Yang
Journal:  Korean J Ophthalmol       Date:  2014-01-21

3.  Combined Tractional and Rhegmatogenous Retinal Detachment in Proliferative Diabetic Retinopathy in the Anti-VEGF Era.

Authors:  Ya-Jui Hsu; Yi-Ting Hsieh; Po-Ting Yeh; Jehn-Yu Huang; Chung-May Yang
Journal:  J Ophthalmol       Date:  2014-06-25       Impact factor: 1.909

4.  The adjunctive use of pre-operative intravitreal bevacizumab in the setting of proliferative diabetic retinopathy.

Authors:  Abdullah Al-Kharashi; Tural Galbinur; Efrem D Mandelcorn; Rajeev H Muni; Mir Nabavi; Peter J Kertes
Journal:  Saudi J Ophthalmol       Date:  2016-10-29

5.  Intravitreal bevacizumab prior to vitrectomy for proliferative diabetic retinopathy: a systematic review.

Authors:  Panagiotis Dervenis; Nikolaos Dervenis; David Steel; Teresa Sandinha; Paris Tranos; Panagiotis Vasilakis; Ioannis Liampas; Chrysoula Doxani; Elias Zintzaras
Journal:  Ther Adv Ophthalmol       Date:  2021-12-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.